DI STEFANO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 9.752
EU - Europa 6.688
AS - Asia 6.359
SA - Sud America 666
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 4
Totale 23.566
Nazione #
US - Stati Uniti d'America 9.557
SG - Singapore 2.623
CN - Cina 1.734
IT - Italia 1.474
IE - Irlanda 861
UA - Ucraina 793
GB - Regno Unito 693
RU - Federazione Russa 636
SE - Svezia 624
VN - Vietnam 619
TR - Turchia 552
FR - Francia 551
BR - Brasile 535
DE - Germania 487
IN - India 312
FI - Finlandia 208
BD - Bangladesh 138
HK - Hong Kong 114
CA - Canada 104
PL - Polonia 65
MX - Messico 55
ES - Italia 53
BE - Belgio 50
AR - Argentina 49
JP - Giappone 45
AT - Austria 38
CZ - Repubblica Ceca 35
IQ - Iraq 34
KR - Corea 28
NL - Olanda 28
ZA - Sudafrica 25
IR - Iran 22
LT - Lituania 21
ID - Indonesia 19
CO - Colombia 17
PK - Pakistan 17
EC - Ecuador 16
SA - Arabia Saudita 16
KE - Kenya 13
MA - Marocco 13
GR - Grecia 12
UZ - Uzbekistan 12
VE - Venezuela 12
JO - Giordania 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
CL - Cile 10
EU - Europa 10
PE - Perù 10
TN - Tunisia 10
EG - Egitto 9
IL - Israele 9
JM - Giamaica 8
PY - Paraguay 8
AZ - Azerbaigian 7
RO - Romania 7
AL - Albania 6
NP - Nepal 6
DK - Danimarca 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EE - Estonia 5
MY - Malesia 5
CR - Costa Rica 4
HN - Honduras 4
KZ - Kazakistan 4
PA - Panama 4
PH - Filippine 4
PT - Portogallo 4
AU - Australia 3
BG - Bulgaria 3
BO - Bolivia 3
CG - Congo 3
ET - Etiopia 3
HU - Ungheria 3
LB - Libano 3
NO - Norvegia 3
TH - Thailandia 3
BB - Barbados 2
BS - Bahamas 2
CI - Costa d'Avorio 2
GY - Guiana 2
HR - Croazia 2
KW - Kuwait 2
MD - Moldavia 2
RS - Serbia 2
SR - Suriname 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
Totale 23.551
Città #
Singapore 1.972
San Jose 1.167
Chandler 1.123
Jacksonville 930
Dublin 848
Ashburn 661
Southend 460
Dallas 444
Beijing 399
Princeton 373
Chieti 332
Izmir 300
Nanjing 266
Santa Clara 239
Los Angeles 233
Dearborn 228
Council Bluffs 212
The Dalles 206
Ho Chi Minh City 203
Ann Arbor 200
New York 184
Wilmington 175
Munich 150
Cambridge 146
Hanoi 144
Altamura 143
Tongling 118
Pescara 112
Hong Kong 98
Nanchang 95
Buffalo 93
Boardman 90
Moscow 79
Shenyang 67
São Paulo 59
Tianjin 54
Woodbridge 53
Brussels 48
Hebei 48
Kunming 48
Redondo Beach 48
Frankfurt am Main 45
Hefei 44
Rome 44
Washington 44
Orem 43
Tokyo 42
Warsaw 42
Helsinki 39
Houston 39
Montreal 35
Chennai 32
Da Nang 32
Brno 31
Denver 31
Atlanta 30
Jinan 30
Milan 30
Grevenbroich 29
Kocaeli 29
London 29
Zhengzhou 29
Dong Ket 28
Brooklyn 27
Chicago 26
Falls Church 26
Jiaxing 26
Toronto 26
Turku 26
Haiphong 25
Leawood 25
Nuremberg 25
Seattle 25
Seoul 24
Mexico City 23
Vienna 23
Augusta 22
Boston 22
Poplar 22
San Francisco 22
Hangzhou 21
Guangzhou 20
Johannesburg 20
Norwalk 20
San Mateo 20
Changsha 19
Ningbo 19
Stockholm 19
Ancona 17
Manchester 17
Bologna 15
Lanciano 15
Rio de Janeiro 15
Ardabil 14
Auburn Hills 14
Biên Hòa 14
Brasília 14
Lanzhou 14
Paris 14
Silvi 14
Totale 14.375
Nome #
Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms 238
Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases 210
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 201
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 197
Preparation of boronate derivatives for the treatment of diseases and conditions associated to oxidative stress 188
Modulation of apoptotic cell death and neuroprotective effects of glutathione—L-Dopa codrug against H2O2-induced cellular toxicity 185
Carvacrol codrugs: A new approach in the antimicrobial plan 182
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 180
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 174
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 172
(R)-α-Lipoyl-Gly-L-Pro-L-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease 171
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 167
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma 166
Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro 165
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 164
Au nanoparticles functionalized by newly synthetised antiparkinson prodrugs 163
Potential Antibacterial Activity of Carvacrol-Loaded PLGA Nanoparticles against Microbial Biofilm 162
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 160
Zingiberene attenuates hydrogen peroxide-induced toxicity in neuronal cells 158
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 158
NSAID Coniugates for the treatment of Alzheimer's Disease 158
Synthesis of a novel TRH-related sulphonamido peptide 157
Effect of MRJF4 on C6 glioma cells proliferation and migration 156
Carvacrol prodrugs as novel antimicrobial agents 156
Preparation and characterization of polymeric micelles loaded with a potential anticancer prodrug 155
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 154
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents 153
Advances in prodrug design for Parkinson's disease 153
A novel TRH analog containing a gamma-sultam residue replacing the pyroglutamic acid 152
Characterization of alkanoyl-10-O-minocyclines in micellar dispersions as potential agents for treatment of human neurodegenerative disorders 152
Ibuprofen and lipoic acid diamide as co-drugs with neuroprotective activity: pharmacological properties and effects in β-amyloid (1-40) infused Alzheimer’s disease rat model. 152
Health risk assessments of lithium titanate nanoparticles in rat liver cell model for its safe applications in nanopharmacology and nanomedicine 152
Emerging Effects of Resveratrol Derivatives in Cells Involved in Oral Wound Healing: A Preliminary Study 151
Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC 149
Carvacrol and its derivatives as antibacterial agents 147
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 146
Cofarmaci L-Dopa-antiossidanti solforati quali nuovi potenziali agenti anti-Parkinson 146
Antiparkinson Prodrugs 145
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 145
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 144
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 143
Single-Walled Carbon Nanotubes in Highly Viscous Media: A Comparison between the Dispersive Agents [BMIM][BF4], L121, and Triton X-100 143
Synthesis and antioxidant properties of novel memantine derivatives 143
A new lipophilic molecular combination codrug-1 exerts neuroprotective activity in beta amyloid (1-40) infused Alzheimer’s disease rat model 142
Synthesis and preliminary evaluation of L-dopa/benserazide conjugates as dual acting codrugs 142
Graphene Oxide increases mammalian spermatozoa fertilizing ability by extracting cholesterol from their membranes and promoting capacitation 142
Sintesi di trans-2-ammino-5(o 6)-cloro-6(o 5)-idrossi-1-fenil-2,3-diidro-1H-indani quali precursori di derivati a potenziale affinità per i recettori della dopamina 141
Gold nanoparticles as scaffolds for new antiparkinson prodrugs 140
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 139
L-Dopa Prodrugs: An Overview of Trends for Improving Parkinson's Disease Treatment 139
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 138
Activity of N-(2-phenylethyl)-N-n-propyl-(2-(3-hydroxyphenyl)ethylamine derivates as dopamine receptor ligands 137
sintesi ed attività di due analoghi del glutatione a conformazione ristretta 137
Nano-delivery systems based on carvacrol prodrugs and fibrous clays 137
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 136
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 136
Design, synthesis and preliminary pharmacological evaluation of new imidazolinones as L-DOPA prodrugs. 136
L-dopa co-drugs in nanostructured lipid carriers: A comparative study 136
Design and synthesis of multifunctional drugs: a strategy to improve the treatment of Parkinson’s disease 135
Evidence for a Dopamine Intrinsic Direct Role in the Regulation of the Ovary Reproductive Function: In Vitro Study on Rabbit Corpora Lutea 135
New drug delivery strategies for improved Parkinson’s disease therapy 134
Synthesis and preliminary pharmacological evaluation of 5-hydroxy and 5,6-dihydroxy-benzo(5,6)cyclohept(1,2,3-ij)isoquinoline derivatives as dopamine receptor ligands 133
Biodegradable microspheres loaded with an antiparkinson prodrug: an in vivo pharmacokinetic study 133
“Evaluation of endocrine disruptors, TPHPand DPHP, effect on DNA repair damage pathwais in a normal human thyroid cell model” 133
Stimulation of Human Macrophages (THP-1) using Toll-like Receptor-2 (TLR-2) Agonist Decorated Nanocarriers 132
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 131
Evaluation of rat striatal L-Dopa and DA concentration after intraperitoneal administration of L- Dopa prodrugs in liposomal formulations 131
Designing Prodrugs for the Treatment of Parkinson's Disease 130
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases 130
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 129
HPLC–FLD and spectrofluorometer apparatus: How to best detect fluorescent probe-loaded niosomes in biological samples 129
Analytical Methods to Best Detect Fluorescent Probe Loading Nanoparticles in Biological Samples 129
Inside Cover: Single-Walled Carbon Nanotubes in Highly Viscous Media: A Comparison between the Dispersive Agents [BMIM][BF4 ], L121, and Triton X-100 (Chem. Eur. J. 2/2016) 129
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 128
Anticancer effects of novel NSAIDs derivatives on cultured human glioblastoma cells 128
Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands. 127
RNAIII Inhibiting Peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections 127
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 126
L-Dopa- and dopamine- (R)-α-lipoic acid conjugates as multifunctional codrugs with antioxidant properties 126
Nanoencapsulation strategies for the delivery of novel bifunctional antioxidant/σ1 selective ligands 126
Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation 126
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 125
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 125
Toll-like receptor-2 agonist functionalized biopolymer for mucosal vaccination 124
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound. 124
Synthesis of a novel glutathione analogue as potential inhibitor of glutathione-S-transferase 123
Direct- and spacer-coupled codrug strategies for the treatment of Alzheimer’s disease 122
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 122
Multiple lipid nanoparticles as antimicrobial drug delivery systems 122
Development of l-Dopa-containing diketopiperazines as blood-brain barrier shuttle 121
Drug Delivery Strategies for Alzheimer's Disease Treatment 121
In vitro evaluation of the potential anticancer activity of new memantin co-drugs on rat C6 glioblastoma cells 121
Role of Dietary Supplements in the Management of Parkinson's Disease 121
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 121
In Vitro Wound-Healing Properties of Water-Soluble Terpenoids Loaded on Halloysite Clay 121
Anti-Obesity and Anti-Inflammatory Effects of Novel Carvacrol Derivatives on 3T3-L1 and WJ-MSCs Cells 120
Maleic- and Fumaric-diamides of (O,O-diacetyl)-L-Dopa-methylester as anti-Parkinson prodrugs in liposomal formulation 120
Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity 120
Synthesis and Biological Evaluation of Novel Cinnamic Acid-Based Antimicrobials 120
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 119
Totale 14.390
Categoria #
all - tutte 98.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.275


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202174 0 0 0 0 0 0 0 0 0 0 0 74
2021/2022918 33 32 13 94 93 33 34 61 131 42 89 263
2022/20233.067 235 464 178 332 280 584 153 281 367 47 66 80
2023/20241.486 99 82 102 54 94 461 318 55 20 24 27 150
2024/20253.806 192 720 616 122 50 225 100 199 312 170 472 628
2025/20267.863 684 363 737 909 693 462 1.382 489 773 652 487 232
Totale 24.188